pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,817 catalysts · 3,312 8k filing · 2,051 grant · 1,024 approval · 1,000 device adverse event · 741 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 28 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-19×clear all
type
  • 8k filing3,312
  • grant2,051
  • approval1,024
  • device adverse event1,000
  • device 510k741
  • earnings584
device pma
543
  • device recall277
  • recall204
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 19, 2026

    24
    ›Jan 23, 2026device recall204d agoI.T.S. GmbH device recall (Cls II)

    Pelvic Reconstruction System (PRS) with the below descriptions and corresponding article numbers. 1. Fixation Screw; Article Number: 70312. 2. Spike short; Article Number: 70314. — Reason: Updated MRI safety testing demonstrates higher RF-induced temperature increases under certain MRI conditions than previously reflected in the Instructions for Use (IFU). — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 23, 2026grant204d agoEMORY UNIVERSITY — Contribution of cell-specific activity to functional MRIEmory University

    NS grant. $577,611. PI: Shella D Keilholz

    full page →nih reporter ↗
    ›Jan 23, 2026grant204d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Understanding kidney failure in individuals with DiGeorge syndrome

    DK grant. $859,998. PI: ROSEMARY V SAMPOGNA

    full page →nih reporter ↗
    ›Jan 24, 2026approval203d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval203d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026approval203d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026approval203d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026device 510k203d agoVydence Medical Industria E Commercio Ltda — Vydence Family of Lasers (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 24, 2026device 510k203d agoGuangzhou Potent Medical Equipment Joint-Stock Co., Ltd. — Holmium Laser Therapeutic Apparatus (HZ-40) (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026grant202d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Ovarian Steroid Mechanisms of Female Cannabis Use: Longitudinal and Experimen...Bedrocan BV

    DA grant. $54,538. PI: Anna Patterson

    full page →nih reporter ↗

    Week of Jan 26, 2026

    26
    ›Jan 26, 2026approval201d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval
    ← prev
    page 5 of 197
    next →
    201d ago
    BETAMETHASONE DIPROPIONATE — FDA approvalBETAMETHASONE DIPROPIONATE

    Sponsor: AUROBINDO PHARMA LTD. Form: CREAM. Route: TOPICAL

    full page →BETAMETHASONE DIPROPIONATE →fda approvals ↗
    ›Jan 26, 2026approval201d agoPALIPERIDONE — FDA approvalpaliperidone ER

    Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →paliperidone ER →fda approvals ↗
    ›Jan 26, 2026approval201d agoMETHYLPREDNISOLONE ACETATE — FDA approvalPFIZER INC

    Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 26, 2026approval201d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Jan 26, 2026approval201d agoFINASTERIDE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval201d agoCHLORPROMAZINE HYDROCHLORIDE — FDA approvalCHLORPROMAZINE HYDROCHLORIDE

    Sponsor: MSN. Form: INJECTABLE. Route: INJECTION

    full page →CHLORPROMAZINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 26, 2026approval201d agoTRANEXAMIC ACID — FDA approvalHyloris Pharmaceuticals SA

    Sponsor: I 3 PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval201d agoDIFLUPREDNATE — FDA approvalDIFLUPREDNATE

    Sponsor: ALEMBIC. Form: EMULSION. Route: OPHTHALMIC

    full page →DIFLUPREDNATE →fda approvals ↗
    ›Jan 26, 2026approval201d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

    Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

    full page →tapentadol hydrochloride ER →fda approvals ↗
    ›Jan 26, 2026approval201d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

    Sponsor: ACCORD HLTHCARE. Form: POWDER. Route: INTRAVENOUS

    full page →Daptomycin Novo →fda approvals ↗
    ›Jan 26, 2026approval201d agoBUDESONIDE — FDA approvalbudesonide DR

    Sponsor: RISING. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →budesonide DR →fda approvals ↗
    ›Jan 26, 2026approval201d agoQUIOFIC (FOLIC ACID) — FDA approvalfolic acid

    Sponsor: SOLUBIOMIX. Form: SOLUTION. Route: ORAL

    full page →folic acid →fda approvals ↗
    ›Jan 26, 2026approval201d agoCUPRIC CHLORIDE — FDA approvalCUPRIC CHLORIDE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →CUPRIC CHLORIDE →fda approvals ↗
    ›Jan 26, 2026device 510k201d agoOutset Medical, Inc. — Tablo Hemodialysis System (PN-0008000, PN-0006000U) (510k cleared)Outset Medical, Inc.

    Product code: KDI. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 26, 2026device 510k201d agoEyas Medical Imaging, Inc. — Ascent3T Neonatal Magnetic Resonance Imaging System (510k cleared)

    Product code: LNH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 26, 2026device 510k201d agoGe Medical Systems Information Technologies, Inc. — MAC 7 Resting ECG Analysis System (510k cleared)

    Product code: DPS. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 26, 2026device pma201d agoDiaSorin, Inc. — LIAISON QuantiFERON TB Gold Plus II; LIAISON Control QuantiFERON TB Gold Plus II (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: NCD. Advisory committee: MI. Decision: APPR

    full page →fda device pma ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 M12 System Model Numbers: (1)722078, (2)722223, (3)722233; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 M20 System Model Numbers: (1)722079, (2)722224, (3)722234, (4)722282(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 B12 System Model Numbers:(1) 722067, (2) 722225, (3) 722235; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 5 M12 System Model Numbers: (1)722227, (2)722231; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 3 M15 System Model Numbers: (1) 722064, (2) 722222, (3) 722230, (4)722280(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 3 M12 System Model Numbers: (1) 722063, (2) 722221, (3) 722229; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 B20 System Model Numbers: (1)722068, (2)722226, (3)722236; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall201d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 5 M20 System Model Numbers: (1)722228, (2)722232, (3)722281(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    $PFE26.61-0.73%
    $AMRX17.66+2.26%
    $OM4.5200-1.09%
    $AMRX17.66+2.26%